S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.34 (+1.09%)
MSFT   331.61 (-0.38%)
META   264.64 (+0.99%)
GOOGL   123.75 (-0.69%)
AMZN   121.30 (+0.99%)
TSLA   198.96 (+3.00%)
NVDA   403.34 (+3.56%)
NIO   7.37 (-4.29%)
BABA   78.59 (-2.94%)
AMD   126.05 (-0.77%)
T   15.64 (+0.90%)
F   12.65 (+4.63%)
MU   72.67 (-1.70%)
CGC   0.87 (-1.33%)
GE   102.03 (-0.69%)
DIS   87.47 (-0.93%)
AMC   4.56 (-1.72%)
PFE   37.08 (-1.38%)
PYPL   61.06 (+1.39%)
NFLX   391.62 (+3.36%)
S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.34 (+1.09%)
MSFT   331.61 (-0.38%)
META   264.64 (+0.99%)
GOOGL   123.75 (-0.69%)
AMZN   121.30 (+0.99%)
TSLA   198.96 (+3.00%)
NVDA   403.34 (+3.56%)
NIO   7.37 (-4.29%)
BABA   78.59 (-2.94%)
AMD   126.05 (-0.77%)
T   15.64 (+0.90%)
F   12.65 (+4.63%)
MU   72.67 (-1.70%)
CGC   0.87 (-1.33%)
GE   102.03 (-0.69%)
DIS   87.47 (-0.93%)
AMC   4.56 (-1.72%)
PFE   37.08 (-1.38%)
PYPL   61.06 (+1.39%)
NFLX   391.62 (+3.36%)
S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.34 (+1.09%)
MSFT   331.61 (-0.38%)
META   264.64 (+0.99%)
GOOGL   123.75 (-0.69%)
AMZN   121.30 (+0.99%)
TSLA   198.96 (+3.00%)
NVDA   403.34 (+3.56%)
NIO   7.37 (-4.29%)
BABA   78.59 (-2.94%)
AMD   126.05 (-0.77%)
T   15.64 (+0.90%)
F   12.65 (+4.63%)
MU   72.67 (-1.70%)
CGC   0.87 (-1.33%)
GE   102.03 (-0.69%)
DIS   87.47 (-0.93%)
AMC   4.56 (-1.72%)
PFE   37.08 (-1.38%)
PYPL   61.06 (+1.39%)
NFLX   391.62 (+3.36%)
S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.34 (+1.09%)
MSFT   331.61 (-0.38%)
META   264.64 (+0.99%)
GOOGL   123.75 (-0.69%)
AMZN   121.30 (+0.99%)
TSLA   198.96 (+3.00%)
NVDA   403.34 (+3.56%)
NIO   7.37 (-4.29%)
BABA   78.59 (-2.94%)
AMD   126.05 (-0.77%)
T   15.64 (+0.90%)
F   12.65 (+4.63%)
MU   72.67 (-1.70%)
CGC   0.87 (-1.33%)
GE   102.03 (-0.69%)
DIS   87.47 (-0.93%)
AMC   4.56 (-1.72%)
PFE   37.08 (-1.38%)
PYPL   61.06 (+1.39%)
NFLX   391.62 (+3.36%)
NASDAQ:DTIL

Precision BioSciences (DTIL) Price Target & Analyst Ratings

$0.75
+0.01 (+1.47%)
(As of 12:39 PM ET)
Compare
Today's Range
$0.74
▼
$0.78
50-Day Range
$0.70
▼
$0.91
52-Week Range
$0.68
▼
$2.21
Volume
201,990 shs
Average Volume
582,839 shs
Market Capitalization
$85.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Precision BioSciences Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 4 Analyst Ratings

Consensus Analyst Price Target

$7.25
866.67% Upside
High Prediction$17.00
Average Prediction$7.25
Low Prediction$2.00
TypeCurrent
5/30/22 to 5/30/23		1 Month Ago
4/30/22 to 4/30/23		3 Months Ago
3/1/22 to 3/1/23		1 Year Ago
5/30/21 to 5/30/22
Consensus Rating
Hold
Hold
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$7.25$7.25$8.00$18.00
Predicted Upside866.67% Upside508.00% Upside479.11% Upside111.45% Upside
Get Precision BioSciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter.


DTIL Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DTIL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Precision BioSciences Stock vs. The Competition

TypePrecision BioSciencesMedical CompaniesS&P 500
Consensus Rating Score
2.25
2.66
2.48
Consensus RatingHoldBuyHold
Predicted Upside880.92% Upside1,325.53% Upside197.55% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/15/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating		P. Trucchio
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingBuy$17.00+1,812.24%
3/13/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Market Perform$7.00 ➝ $4.00+330.34%
11/15/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$6.00+302.68%
8/9/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetNeutral$3.00 ➝ $2.00+24.22%
6/9/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating		R. Prasad
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeOutperform ➝ Market Perform
(Data available from 5/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












DTIL Price Target - Frequently Asked Questions

What is Precision BioSciences's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for Precision BioSciences stock is Hold based on the current 3 hold ratings and 1 buy rating for DTIL. The average twelve-month price prediction for Precision BioSciences is $7.25 with a high price target of $17.00 and a low price target of $2.00. Learn more on DTIL's analyst rating history.

Do Wall Street analysts like Precision BioSciences more than its competitors?

Analysts like Precision BioSciences less than other Medical companies. The consensus rating for Precision BioSciences is Hold while the average consensus rating for medical companies is Buy. Learn more on how DTIL compares to other companies.

Is Precision BioSciences being downgraded by Wall Street analysts?

Over the previous 90 days, Precision BioSciences's stock had 1 downgrade by analysts.

Does Precision BioSciences's stock price have much upside?

According to analysts, Precision BioSciences's stock has a predicted upside of 508.00% based on their 12-month price targets.

What analysts cover Precision BioSciences?

Precision BioSciences has been rated by BMO Capital Markets, and HC Wainwright in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:DTIL) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -